|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van den Berg H, Kroon HM, Slaar A and
Hogendoorn P: Incidence of biopsy-proven bone tumors in children: A
report based on the Dutch pathology registration ‘PALGA’. J Pediatr
Orthop. 28:29–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
PosthumaDeBoer J, Witlox MA, Kaspers GJ
and van Royen BJ: Molecular alterations as target for therapy in
metastatic osteosarcoma: A review of literature. Clin Exp
Metastasis. 28:493–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhan YH, Liu J, Qu XJ, Hou KZ, Wang KF,
Liu YP and Wu B: β-Elemene induces apoptosis in human renal-cell
carcinoma 786-0 cells through inhibition of MAPK/ERK and
PI3K/Akt/mTOR signalling pathways. Asian Pac J Cancer Prev.
13:2739–2744. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang G, Li X, Huang F, et al: Elemene, a
novel anticancer drug, triggers cell death and enhances cisplatin
sensitivity via induction of apoptosis and cell cycle arrest in
human non-small cell lung cancer cells. Cancer Res. 64:689.
2004.PubMed/NCBI
|
|
6
|
Kai LI, Cong X and Zhao X: The inhibitory
effect of Xiaoaiping combined with elemene on cell proliferation
and expression of Bcl-2 protein in cervix cancer HeLa cells. Chin J
Clin Oncol. 35:705–561. 2008.
|
|
7
|
Li QQ, Wang G, Zhang M, Cuff CF, Huang L
and Reed E: beta-Elemene, a novel plant-derived antineoplastic
agent, increases cisplatin chemosensitivity of lung tumor cells by
triggering apoptosis. Oncol Rep. 22:161–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou HY, Shen JK, Hou JS, Qiu YM and Luo
QZ: Experimental study on apoptosis induced by elemene in glioma
cells. Ai Zheng. 22:959–963. 2003.(In Chinese). PubMed/NCBI
|
|
9
|
Liang D, Yang M, Guo B, Yang L, Cao J and
Zhang X: HIF-1α induced by β-elemene protects human osteosarcoma
cells from undergoing apoptosis. J Cancer Res Clin Oncol.
138:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ender SA, Dallmer A, Lässig F, Lendeckel U
and Wolke C: Expression and function of the
ACE2/angiotensin(1–7)/Mas axis in osteosarcoma cell lines U-2 OS
and MNNG-HOS. Mol Med Rep. 10:804–810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fromigué O, Haÿ E, Modrowski D, Bouvet S,
Jacquel A, Auberger P and Marie PJ: RhoA GTPase inactivation by
statins induces osteosarcoma cell apoptosis by inhibiting
p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell
differentiation. Cell Death Differ. 13:1845–1856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gatti L, Cossa G, Tinelli S, et al:
Improved apoptotic cell death in drug-resistant non small cell lung
cancer cells by TRAIL-based treatment. J Pharmacol Exp Ther.
194–201. 2013.
|
|
13
|
Ball DW, Jin N, Rosen DM, Dackiw A,
Sidransky D, Xing M and Nelkin BD: Selective growth inhibition in
BRAF mutant thyroid cancer by the mitogen-activated protein kinase
kinase 1/2 inhibitor AZD6244. J Clin Endocrinol Metab.
92:4712–4718. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krajewska M, Krajewski S, Epstein JI,
Shabaik A, Sauvageot J, Song K, Kitada S and Reed JC:
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1
expression in prostate cancer. Am J Pathol. 148:1567–1576.
1996.PubMed/NCBI
|
|
15
|
Bangalore S: Renin-angiotensin system
inhibitors and risk of cancer. Trends Mol Med. 17:176–177. 2011.
View Article : Google Scholar
|
|
16
|
Wang SR, Sang WK and Kim CJ: Overview of
the Renin-Angiotensin system. Korean Circ J. 37:91–96. 2007.
View Article : Google Scholar
|
|
17
|
Li X, Wang G, Zhao J, Ding H, Cunningham
C, Chen F, Flynn DC, Reed E and Li QQ: Antiproliferative effect of
beta-elemene in chemoresistant ovarian carcinoma cells is mediated
through arrest of the cell cycle at the G2-M phase. Cell Mol Life
Sci. 62:894–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of beta-elemene in non-small-cell lung cancer cells is mediated via
induction of cell cycle arrest and apoptotic cell death. Cell Mol
Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng S, Yang H, Zhang S, Wang X, Yu L, Lu
J and Li J: Initial study on naturally occurring products from
traditional Chinese herbs and vegetables for chemoprevention. J
Cell Biochem Suppl. 27:106–112. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li QQ, Wang G, Huang F, Banda M and Reed
E: Antineoplastic effect of beta-elemene on prostate cancer cells
and other types of solid tumour cells. J Pharm Pharmacol.
62:1018–1027. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li CL, Chang L, Guo L, Zhao D, Liu HB,
Wang QS, Zhang P, Du WZ, Liu X, Zhang HT, et al: β-elemene induces
caspase-dependent apoptosis in human glioma cells in vitro through
the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Asian Pac J Cancer Prev. 15:10407–10412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ
and Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells
depends on p38 MAPK activation. Cancer Lett. 264:127–134. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen W, Lu Y, Wu J, Gao M, Wang A and Xu
B: Beta-elemene inhibits melanoma growth and metastasis via
suppressing vascular endothelial growth factor-mediated
angiogenesis. Cancer Chemother Pharmacol. 67:799–808. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie CY, Yang W, Li M, Ying J, Tao SJ, Li
K, Dong JH and Wang XS: Cell apoptosis induced by delta-elemene in
colorectal adenocarcinoma cells via a mitochondrial-mediated
pathway. Yakugaku Zasshi. 129:1403–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
George AJ, Thomas WG and Hannan RD: The
renin-angiotensin system and cancer: Old dog, new tricks. Nat Rev
Cancer. 10:745–759. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dougherty U, Mustafi R, Sadiq F,
Almoghrabi A, Mustafi D, Kreisheh M, Sundaramurthy S, Liu W, Konda
VJ, Pekow J, et al: The renin-angiotensin system mediates EGF
receptor-vitamin d receptor cross-talk in colitis-associated colon
cancer. Clin Cancer Res. 20:5848–5859. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tamarat R, Silvestre JS, Durie M and Levy
BI: Angiotensin II angiogenic effect in vivo involves vascular
endothelial growth factor- and inflammation-related pathways. Lab
Invest. 82:747–756. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pupilli C, Lasagni L, Romagnani P, Bellini
F, Mannelli M, Misciglia N, Mavilia C, Vellei U, Villari D and
Serio M: Angiotensin II stimulates the synthesis and secretion of
vascular permeability factor/vascular endothelial growth factor in
human mesangial cells. J Am Soc Nephrol. 10:245–255.
1999.PubMed/NCBI
|
|
29
|
Otani A, Takagi H, Oh H, Koyama S and
Honda Y: Angiotensin II induces expression of the Tie2 receptor
ligand, angiopoietin-2, in bovine retinal endothelial cells.
Diabetes. 50:867–875. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujita M, Hayashi I, Yamashina S, Itoman M
and Majima M: Blockade of angiotensin AT1a receptor signaling
reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys
Res Commun. 294:441–447. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deshayes F and Nahmias C: Angiotensin
receptors: A new role in cancer? Trends Endocrinol Metab.
16:293–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
